Reporting owner · Q3 2026 · CIK 1920553

Reich Kristian: insider trades.

Reich Kristian reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.3M), across 1 company.

Transactions
5
Purchases (P)
0
Sales (S)
5
Companies
1
Name as filed
Reich Kristian

Companies

CompanyRelationshipTransactions
MoonLake Immunotherapeutics (MLTX)Officer · Chief Scientific Officer5

Transactions

5 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-07-27MoonLake ImmunotherapeuticsS1,100$202,711,198Form 4
2026-07-22MoonLake ImmunotherapeuticsS2,448$202,712,298Form 4
2026-07-21MoonLake ImmunotherapeuticsS50,000$20.022,714,746Form 4
2026-07-20MoonLake ImmunotherapeuticsS43,700$20.092,764,746Form 4
2026-07-15MoonLake ImmunotherapeuticsS16,105$20.012,808,446Form 4

Questions

What stock did Reich Kristian buy or sell?

Reich Kristian reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.3M), across 1 company.

Is Reich Kristian the same person as other filers with this name?

This page covers SEC CIK 1920553 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/reich-kristian-1920553.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.